Drugs / rHAO Trivalent Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00170443 | ? → Jun 2004 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rHAO Trivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00170443 ↗ |
| Modality | Vaccine | “experimental recombinant influenza HA protein vaccine” NCT00170443 ↗ |
| Route | Intramuscular | “Intramuscular Trivalent Baculovirus-expressed Influenza HA Vaccine” NCT00170443 ↗ |